New therapeutic approaches to subarachnoid hemorrhage

Bibliography

• Ingall T, Asplund K, Mahonen M, A multinational comparison of subarachnoid hemorrhage epidemiology in the WHO MONICA stroke study. Stroke 2000;31:1054-61
   PubMed Web of Science ®Google Scholar
• Dimopoulou I, Kouyialis AT, Tzanella M, High incidence of neuroendocrine dysfunction in long-term survivors of aneurysmal subarachnoid hemorrhage. Stroke 2004;35:2884-9
   PubMed Web of Science ®Google Scholar
• Miyazaki T, Ohta F, Moritake K, The key to improving prognosis for aneurysmal subarachnoid hemorrhage remains in the pre-hospitalization period. Surg Neurol 2006;65:360-5
   PubMed Web of Science ®Google Scholar
• Ohkuma H, Tsurutani H, Suzuki S. Incidence and significance of early aneurysmal rebleeding before neurosurgical or neurological management. Stroke 2001;32:1176-80
   PubMed Web of Science ®Google Scholar
• Rabinstein AA, Weigand S, Atkinson JL, Patterns of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke 2005;36:992-7
   PubMed Web of Science ®Google Scholar
• Soehle M, Chatfield DA, Czosnyka M, Predictive value of initial clinical status, intracranial pressure and transcranial Doppler pulsatility after subarachnoid haemorrhage. Acta Neurochir (Wien) 2007;149:575-83
   PubMed Web of Science ®Google Scholar
• Rasulo FA, Girardini A, Lavinio A, Are optimal cerebral perfusion pressure and cerebrovascular autoregulation related to long-term outcome in patients with aneurysmal subarachnoid hemorrhage? J Neurosurg Anesthesiol 2011;24:3-8
   Web of Science ®Google Scholar
• Bederson JB, Levy AL, Ding WH, Acute vasoconstriction after subarachnoid hemorrhage. Neurosurgery 1998;42:352-60
   PubMed Web of Science ®Google Scholar
• Schubert GA, Seiz M, Hegewald AA, Hypoperfusion in the acute phase of subarachnoid hemorrhage. Acta Neurochir Suppl 2011;110:35-8
   PubMedGoogle Scholar
• Heros RC, Zervas NT, Varsos V. Cerebral vasospasm after subarachnoid hemorrhage: an update. Ann Neurol 1983;14:599-608
   PubMed Web of Science ®Google Scholar
• Vergouwen MD, Ilodigwe D, Macdonald RL. Cerebral infarction after subarachnoid hemorrhage contributes to poor outcome by vasospasm-dependent and -independent effects. Stroke 2011;42:924-9
   PubMed Web of Science ®Google Scholar
• Czosnyka M, Steiner L, Balestreri M, Concept of “true ICP” in monitoring and prognostication in head trauma. Acta Neurochir Suppl 2005;95:341-4
   PubMedGoogle Scholar
• Scholler K, Trinkl A, Klopotowski M, Characterization of microvascular basal lamina damage and blood-brain barrier dysfunction following subarachnoid hemorrhage in rats. Brain Res 2007;1142:237-46
   PubMed Web of Science ®Google Scholar
• Sehba FA, Friedrich V Jr, Makonnen G, Acute cerebral vascular injury after subarachnoid hemorrhage and its prevention by administration of a nitric oxide donor. J Neurosurg 2007;106:321-9
   PubMed Web of Science ®Google Scholar
• Helbok R, Ko SB, Schmidt JM, Global cerebral edema and brain metabolism after subarachnoid hemorrhage. Stroke 2011;42:1534-9
   PubMed Web of Science ®Google Scholar
• Sehba FA, Mostafa G, Friedrich V Jr, Acute microvascular platelet aggregation after subarachnoid hemorrhage. J Neurosurg 2005;102:1094-100
   PubMed Web of Science ®Google Scholar
• Dreier JP, Woitzik J, Fabricius M, Delayed ischaemic neurological deficits after subarachnoid haemorrhage are associated with clusters of spreading depolarizations. Brain 2006;129:3224-37
   PubMed Web of Science ®Google Scholar
• Tomycz L, Shekhawat N, Forbes J, The spectrum of management practices in nontraumatic subarachnoid hemorrhage: a survey of high-volume centers in the United States. Surg Neurol Int 2011;2:90
   PubMedGoogle Scholar
• Bederson JB, Connolly ES Jr, Batjer HH, Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 2009;40:994-1025
   PubMed Web of Science ®Google Scholar
• Guo LM, Zhou HY, Xu JW, Risk factors related to aneurysmal rebleeding. World Neurosurg 2011;76:292-8
   PubMed Web of Science ®Google Scholar
• Dunn LT. Raised intracranial pressure. J Neurol Neurosurg Psychiatry 2007;73:i23-i7
   Google Scholar
• Barry CM, Helps SC, den Heuvel C, Characterizing the role of the neuropeptide substance P in experimental subarachnoid hemorrhage. Brain Res 2011;1389:143-51
   PubMed Web of Science ®Google Scholar
• Doczi T. The pathogenetic and prognostic significance of blood-brain barrier damage at the acute stage of aneurysmal subarachnoid haemorrhage. Clinical and experimental studies. Acta Neurochir (Wien) 1985;77:110-32
   PubMed Web of Science ®Google Scholar
• Park S, Yamaguchi M, Zhou C, Neurovascular protection reduces early brain injury after subarachnoid hemorrhage. Stroke 2004;35:2412-17
   PubMed Web of Science ®Google Scholar
• Chovanes GI, Richards RM. The predominance of metabolic regulation of cerebral blood flow and the lack of “Classic” autoregulation curves in the viable brain. Surg Neurol Int 2012;3:12
   PubMedGoogle Scholar
• Tseng MY, Czosnyka M, Richards H, Effects of acute treatment with statins on cerebral autoregulation in patients after aneurysmal subarachnoid hemorrhage. Neurosurg Focus 2006;21:E10
   PubMedGoogle Scholar
• Treggiari MM. Hemodynamic management of subarachnoid hemorrhage. Neurocrit Care 2011;15:329-35
   PubMed Web of Science ®Google Scholar
• Rabinstein AA, Bruder N. Management of hyponatremia and volume contraction. Neurocrit Care 2011;15:354-60
   PubMed Web of Science ®Google Scholar
• Rosner MJ, Becker DP. Origin and evolution of plateau waves. Experimental observations and a theoretical model. J Neurosurg 1984;60:312-24
   PubMed Web of Science ®Google Scholar
• Kavanagh RJ, Kam PC. Lazaroids: efficacy and mechanism of action of the 21-aminosteroids in neuroprotection. Br J Anaesth 2001;86:110-19
   PubMed Web of Science ®Google Scholar
• Edvinsson L. Neuropeptide Y and the cerebral circulatin. In: Zukowska ZaF GZ, editor. NPY Family of Peptides in Neurobiology, Cardiovascular and Metabolic Disorders: from Genes to Therapeutics. Birkhauser Verlag; Switzerland: 2006. p. 105-12
   Google Scholar
• Weidauer S, Lanfermann H, Raabe A, Impairment of cerebral perfusion and infarct patterns attributable to vasospasm after aneurysmal subarachnoid hemorrhage: a prospective MRI and DSA study. Stroke 2007;38:1831-6
   PubMed Web of Science ®Google Scholar
• Alaraj A, Wallace A, Mander N, Outcome following symptomatic cerebral vasospasm on presentation in aneurysmal subarachnoid hemorrhage: coiling vs. clipping. World Neurosurg 2010;74:138-42
   PubMed Web of Science ®Google Scholar
• Ansar S, Vikman P, Nielsen M, Cerebrovascular ETB, 5-HT1B, and AT1 receptor upregulation correlates with reduction in regional CBF after subarachnoid hemorrhage. Am J Physiol Heart Circ Physiol 2007;293:H3750-8
   PubMed Web of Science ®Google Scholar
• Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980;6:1-9
   PubMed Web of Science ®Google Scholar
• Sercombe R, Dinh YR, Gomis P. Cerebrovascular inflammation following subarachnoid hemorrhage. Jpn J Pharmacol 2002;88:227-49
   PubMedGoogle Scholar
• Wickman G, Lan C, Vollrath B. Functional roles of the rho/rho kinase pathway and protein kinase C in the regulation of cerebrovascular constriction mediated by hemoglobin: relevance to subarachnoid hemorrhage and vasospasm. Circ Res 2003;92:809-16
   PubMed Web of Science ®Google Scholar
• Sobey CG, Quan L. Impaired cerebral vasodilator responses to NO and PDE V inhibition after subarachnoid hemorrhage. Am J Physiol 1999;277:H1718-24
   PubMed Web of Science ®Google Scholar
• Uhl E, Lehmberg J, Steiger HJ, Intraoperative detection of early microvasospasm in patients with subarachnoid hemorrhage by using orthogonal polarization spectral imaging. Neurosurgery 2003;52:1307-15
   PubMed Web of Science ®Google Scholar
• Ellis EM. Reactive carbonyls and oxidative stress: potential for therapeutic intervention. Pharmacol Ther 2007;115:13-24
   PubMed Web of Science ®Google Scholar
• Alexandrova ML, Bochev PG. Oxidative stress during the chronic phase after stroke. Free Radic Biol Med 2005;39:297-316
   PubMed Web of Science ®Google Scholar
• Werner C, Engelhard K. Pathophysiology of traumatic brain injury. Br J Anaesth 2007;99:4-9
   PubMed Web of Science ®Google Scholar
• Gaetani P, Marzatico F, Rodriguez y Baena R, Arachidonic acid metabolism and pathophysiologic aspects of subarachnoid hemorrhage in rats. Stroke 1990;21:328-32
   PubMed Web of Science ®Google Scholar
• Lin CL, Hsu YT, Lin TK, Increased levels of F2-isoprostanes following aneurysmal subarachnoid hemorrhage in humans. Free Radic Biol Med 2006;40:1466-73
   PubMed Web of Science ®Google Scholar
• Pyne-Geithman GJ, Caudell DN, Glutathione peroxidase and subarachnoid hemorrhage: implications for the role of oxidative stress in cerebral vasospasm. Neurol Res 2009;31:195-9
   PubMed Web of Science ®Google Scholar
• Marzatico F, Gaetani P, Rodriguez y Baena R, Bioenergetics of different brain areas after experimental subarachnoid hemorrhage in rats. Stroke 1988;19:378-84
   PubMed Web of Science ®Google Scholar
• Marzatico F, Gaetani P, Cafe C, Antioxidant enzymatic activities after experimental subarachnoid hemorrhage in rats. Acta Neurol Scand 1993;87:62-6
   PubMed Web of Science ®Google Scholar
• Gaetani P, Pasqualin A, Rodriguez y Baena R, Oxidative stress in the human brain after subarachnoid hemorrhage. J Neurosurg 1998;89:748-54
   PubMed Web of Science ®Google Scholar
• Sehba FA, Pluta RM, Zhang JH. Metamorphosis of subarachnoid hemorrhage research: from delayed vasospasm to early brain injury. Mol Neurobiol 2011;43:27-40
   PubMed Web of Science ®Google Scholar
• Beaulieu C, Busch E, de Crespigny A, Spreading waves of transient and prolonged decreases in water diffusion after subarachnoid hemorrhage in rats. Magn Reson Med 2000;44:110-16
   PubMed Web of Science ®Google Scholar
• Dreier JP. The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease. Nat Med 2011;17:439-47
   PubMed Web of Science ®Google Scholar
• Mies G, Paschen W. Regional changes of blood flow, glucose, and ATP content determined on brain sections during a single passage of spreading depression in rat brain cortex. Exp Neurol 1984;84:249-58
   PubMed Web of Science ®Google Scholar
• Dreier JP, Korner K, Ebert N, Nitric oxide scavenging by hemoglobin or nitric oxide synthase inhibition by N-nitro-L-arginine induces cortical spreading ischemia when K+ is increased in the subarachnoid space. J Cereb Blood Flow Metab 1998;18:978-90
   PubMed Web of Science ®Google Scholar
• Petzold GC, Einhaupl KM, Dirnagl U, Ischemia triggered by spreading neuronal activation is induced by endothelin-1 and hemoglobin in the subarachnoid space. Ann Neurol 2003;54:591-8
   PubMed Web of Science ®Google Scholar
• Bosche B, Graf R, Ernestus RI, Recurrent spreading depolarizations after subarachnoid hemorrhage decreases oxygen availability in human cerebral cortex. Ann Neurol 2010;67:607-17
   PubMed Web of Science ®Google Scholar
• Ostrowski RP, Colohan AR, Zhang JH. Mechanisms of hyperbaric oxygen-induced neuroprotection in a rat model of subarachnoid hemorrhage. J Cereb Blood Flow Metab 2005;25:554-71
   PubMed Web of Science ®Google Scholar
• Sehba FA, Friedrich V. Early micro vascular changes after subarachnoid hemorrhage. Acta Neurochir Suppl 2011;110:49-55
   PubMedGoogle Scholar
• Friedrich V, Flores R, Muller A, Escape of intraluminal platelets into brain parenchyma after subarachnoid hemorrhage. Neuroscience 2010;165:968-75
   PubMed Web of Science ®Google Scholar
• Friedrich V, Flores R, Muller A, Reduction of neutrophil activity decreases early microvascular injury after subarachnoid haemorrhage. J Neuroinflammation 2011;8:103
   PubMed Web of Science ®Google Scholar
• Akopov S, Sercombe R, Seylaz J. Cerebrovascular reactivity: role of endothelium/platelet/leukocyte interactions. Cerebrovasc Brain Metab Rev 1996;8:11-94
   PubMedGoogle Scholar
• Yan J, Li L, Khatibi NH, Blood-brain barrier disruption following subarchnoid hemorrhage may be faciliated through PUMA induction of endothelial cell apoptosis from the endoplasmic reticulum. Exp Neurol 2011;230:240-7
   PubMed Web of Science ®Google Scholar
• Feigin VL, Anderson N, Rinkel GJ, Corticosteroids for aneurysmal subarachnoid haemorrhage and primary intracerebral haemorrhage. Cochrane Database Syst Rev 2005;CD004583
   Google Scholar
• Gomis P, Graftieaux JP, Sercombe R, Randomized, double-blind, placebo-controlled, pilot trial of high-dose methylprednisolone in aneurysmal subarachnoid hemorrhage. J Neurosurg 2010;112:681-8
   PubMed Web of Science ®Google Scholar
• Chou SH, Feske SK, Simmons SL, Elevated peripheral neutrophils and matrix metalloproteinase 9 as biomarkers of functional outcome following subarachnoid hemorrhage. Transl Stroke Res 2011;2:600-7
   PubMed Web of Science ®Google Scholar
• Kruyt ND, Biessels GJ, de Haan RJ, Hyperglycemia and clinical outcome in aneurysmal subarachnoid hemorrhage: a meta-analysis. Stroke 2009;40:e424-30
   PubMed Web of Science ®Google Scholar
• Schlenk F, Vajkoczy P, Sarrafzadeh A. Inpatient hyperglycemia following aneurysmal subarachnoid hemorrhage: relation to cerebral metabolism and outcome. Neurocrit Care 2009;11:56-63
   PubMed Web of Science ®Google Scholar
• Schmutzhard E, Rabinstein AA. Spontaneous subarachnoid hemorrhage and glucose management. Neurocrit Care 2011;15:281-6
   PubMed Web of Science ®Google Scholar
• Barth M, Capelle HH, Munch E, Effects of the selective endothelin A (ET(lA)) receptor antagonist clazosentan on cerebral perfusion and cerebral oxygenation following severe subarachnoid hemorrhage – preliminary results from a randomized clinical series. Acta Neurochir (Wien) 2007;149:911-18
   PubMed Web of Science ®Google Scholar
• Gauna C, van den Berghe GH, van der Lely AJ. Pituitary function during severe and life-threatening illnesses. Pituitary 2005;8:213-17
   PubMedGoogle Scholar
• Naredi S, Lambert G, Eden E, Increased sympathetic nervous activity in patients with nontraumatic subarachnoid hemorrhage. Stroke 2000;31:901-6
   PubMed Web of Science ®Google Scholar
• Barth E, Albuszies G, Baumgart K, Glucose metabolism and catecholamines. Crit Care Med 2007;35:S508-18
   PubMed Web of Science ®Google Scholar
• Seematter G, Binnert C, Martin JL, Relationship between stress, inflammation and metabolism. Curr Opin Clin Nutr Metab Care 2004;7:169-73
   PubMed Web of Science ®Google Scholar
• Hunt DG, Ivy JL. Epinephrine inhibits insulin-stimulated muscle glucose transport. J Appl Physiol 2002;93(5):1638-43
   PubMed Web of Science ®Google Scholar
• Hendryk S, Jarzab B, Josko J. Increase of the IL-1 beta and IL-6 levels in CSF in patients with vasospasm following aneurysmal SAH. Neuro Endocrinol Lett 2004;25:141-7
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS, Spiegelman BM. Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 1994;43:1271-8
   PubMed Web of Science ®Google Scholar
• Esposito K, Nappo F, Marfella R, Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002;106:2067-72
   PubMed Web of Science ®Google Scholar
• Schlenk F, Sarrafzadeh AS. Is continuous insulin treatment safe in aneurysmal subarachnoid hemorrhage? Vasc Health Risk Manag 2008;4:885-91
   PubMedGoogle Scholar
• Phillips TJ, Dowling RJ, Yan B, Does treatment of ruptured intracranial aneurysms within 24 hours improve clinical outcome? Stroke 2011;42:1936-45
   PubMed Web of Science ®Google Scholar
• Roos YB, Rinkel GJ, Vermeulen M, Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2003;CD001245
   Google Scholar
• Gaberel T, Magheru C, Emery E, Antifibrinolytic therapy in the management of aneurismal subarachnoid hemorrhage revisited. A meta-analysis. Acta Neurochir (Wien) 2012;154:1-9
   PubMed Web of Science ®Google Scholar
• Muench E, Horn P, Bauhuf C, Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage. Crit Care Med 2007;35:1844-51
   PubMed Web of Science ®Google Scholar
• Le Roux PD. Anemia and transfusion after subarachnoid hemorrhage. Neurocrit Care 2011;15:342-53
   PubMed Web of Science ®Google Scholar
• Dhar R, Zazulia AR, Videen TO, Red blood cell transfusion increases cerebral oxygen delivery in anemic patients with subarachnoid hemorrhage. Stroke 2009;40:3039-44
   PubMed Web of Science ®Google Scholar
• Mutoh T, Ishikawa T, Suzuki A, Continuous cardiac output and near-infrared spectroscopy monitoring to assist in management of symptomatic cerebral vasospasm after subarachnoid hemorrhage. Neurocrit Care 2010;13:331-8
   PubMed Web of Science ®Google Scholar
• Chittiboina P, Conrad S, McCarthy P, The evolving role of hemodilution in treatment of cerebral vasospasm: a historical perspective. World Neurosurg 2011;75:660-4
   PubMedGoogle Scholar
• Liu G, Luo J, Zhang L, Meta-analysis of the effectiveness and safety of prophylactic use of nimodipine in patients with an aneurysmal subarachnoid haemorrhage. CNS Neurol Disord Drug Targets 2011;10:834-44
   PubMed Web of Science ®Google Scholar
• Petruk KC, West M, Mohr G, Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial. J Neurosurg 1988;68:505-17
   PubMed Web of Science ®Google Scholar
• Nogueira RG, Lev MH, Roccatagliata L, Intra-arterial nicardipine infusion improves CT perfusion-measured cerebral blood flow in patients with subarachnoid hemorrhage-induced vasospasm. AJNR Am J Neuroradiol 2009;30:160-4
   PubMed Web of Science ®Google Scholar
• Dorhout Mees SM, Rinkel GJ, Feigin VL, Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2007;CD000277
   PubMed Web of Science ®Google Scholar
• Barth M, Capelle HH, Weidauer S, Effect of nicardipine prolonged-release implants on cerebral vasospasm and clinical outcome after severe aneurysmal subarachnoid hemorrhage: a prospective, randomized, double-blind phase IIa study. Stroke 2007;38:330-6
   PubMed Web of Science ®Google Scholar
• Schneider UC, Dreher S, Hoffmann KT, The use of nicardipine prolonged release implants (NPRI) in microsurgical clipping after aneurysmal subarachnoid haemorrhage: comparison with endovascular treatment. Acta Neurochir (Wien) 2011;153:2119-25
   PubMed Web of Science ®Google Scholar
• Kasuya H. Clinical trial of nicardipine prolonged-release implants for preventing cerebral vasospasm: multicenter cooperative study in Tokyo. Acta Neurochir Suppl 2011;110:165-7
   PubMedGoogle Scholar
• Macdonald RL, Higashida RT, Keller E, Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol 2011;10:618-25
   PubMed Web of Science ®Google Scholar
• Macdonald RL, Kassell NF, Mayer S, Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke 2008;39:3015-21
   PubMed Web of Science ®Google Scholar
• Pradilla G, Garzon-Muvdi T, Ruzevick JJ, Systemic L-citrulline prevents cerebral vasospasm in haptoglobin 2-2 transgenic mice after subarachnoid hemorrhage. Neurosurgery 2012;70:747-56
   PubMed Web of Science ®Google Scholar
• Han BH, Vellimana AK, Zhou ML, Phosphodiesterase 5 inhibition attenuates cerebral vasospasm and improves functional recovery after experimental subarachnoid hemorrhage. Neurosurgery 2012;70:178-86
   PubMed Web of Science ®Google Scholar
• Agrawal A, Patir R, Kato Y, Role of intraventricular sodium nitroprusside in vasospasm secondary to aneurysmal subarachnoid haemorrhage: a 5-year prospective study with review of the literature. Minim Invasive Neurosurg 2009;52:5-8
   PubMed Web of Science ®Google Scholar
• Pluta RM, Oldfield EH, Bakhtian KD, Safety and feasibility of long-term intravenous sodium nitrite infusion in healthy volunteers. PLoS One 2011;6:e14504
   PubMed Web of Science ®Google Scholar
• Asano T, Matsui T. Antioxidant therapy against cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Cell Mol Neurobiol 1999;19:31-44
   PubMed Web of Science ®Google Scholar
• van den Bergh WM, Algra A, van Kooten F, Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke 2005;36:1011-15
   PubMed Web of Science ®Google Scholar
• Schmid-Elsaesser R, Kunz M, Zausinger S, Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study. Neurosurgery 2006;58:1054-65
   PubMed Web of Science ®Google Scholar
• Chyatte D, Fode NC, Nichols DA, Preliminary report: effects of high dose methylprednisolone on delayed cerebral ischemia in patients at high risk for vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery 1987;21:157-60
   PubMed Web of Science ®Google Scholar
• Tseng MY, Czosnyka M, Richards H, Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial. Stroke 2005;36:1627-32
   PubMed Web of Science ®Google Scholar
• Tseng MY, Hutchinson PJ, Turner CL, Biological effects of acute pravastatin treatment in patients after aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled trial. J Neurosurg 2007;107:1092-100
   PubMed Web of Science ®Google Scholar
• Fei L, Golwa F. Topical application of dexamethasone to prevent cerebral vasospasm after aneurysmal subarachnoid haemorrhage: a pilot study. Clin Drug Investig 2007;27:827-32
   PubMed Web of Science ®Google Scholar
• Mutoh T, Kobayashi S, Tamakawa N, Multichannel near-infrared spectroscopy as a tool for assisting intra-arterial fasudil therapy for diffuse vasospasm after subarachnoid hemorrhage. Surg Neurol Int 2011;2:68
   PubMedGoogle Scholar
• Liu GJ, Wang ZJ, Wang YF, Systematic assessment and meta-analysis of the efficacy and safety of fasudil in the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage. Eur J Clin Pharmacol 2012;68:131-9
   PubMed Web of Science ®Google Scholar
• Zhao J, Zhou D, Guo J, Efficacy and safety of fasudil in patients with subarachnoid hemorrhage: final results of a randomized trial of fasudil versus nimodipine. Neurol Med Chir (Tokyo) 2011;51:679-83
   PubMed Web of Science ®Google Scholar
• Dorhout Mees SM, van den Bergh WM, Algra A, Achieved serum magnesium concentrations and occurrence of delayed cerebral ischaemia and poor outcome in aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 2007;78:729-31
   PubMed Web of Science ®Google Scholar
• Mori K, Yamamoto T, Miyazaki M, Effect of intrathecal magnesium sulfate solution injection via a microcatheter in the cisterna magna on cerebral vasospasm in the canine subarachnoid haemorrhage model. Br J Neurosurg 2012;26:64-8
   PubMed Web of Science ®Google Scholar
• Westermaier T, Stetter C, Vince GH, Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, clinical study. Crit Care Med 2010;38:1284-90
   PubMed Web of Science ®Google Scholar
• Prevedello DM, Cordeiro JG, de Morais AL, Magnesium sulfate: role as possible attenuating factor in vasospasm morbidity. Surg Neurol 2006;65(Suppl 1):14-20
   Google Scholar
• Stippler M, Crago E, Levy EI, Magnesium infusion for vasospasm prophylaxis after subarachnoid hemorrhage. J Neurosurg 2006;105:723-9
   PubMed Web of Science ®Google Scholar
• Muroi C, Terzic A, Fortunati M, Magnesium sulfate in the management of patients with aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, dose-adapted trial. Surg Neurol 2008;69:33-9
   PubMed Web of Science ®Google Scholar
• Wong GK, Boet R, Poon WS, Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage: an updated systemic review and meta-analysis. Crit Care 2011;15:R52
   PubMed Web of Science ®Google Scholar
• Dorhout Mees SM. Magnesium in aneurysmal subarachnoid hemorrhage (MASH II) phase III clinical trial MASH-II study group. Int J Stroke 2008;3:63-5
   PubMed Web of Science ®Google Scholar
• McGirt MJ, Woodworth GF, Pradilla G, Galbraith award: simvastatin attenuates experimental cerebral vasospasm and ameliorates serum markers of neuronal and endothelial injury in patients after subarachnoid hemorrhage: a dose-response effect dependent on endothelial nitric oxide synthase. Clin Neurosurg 2005;52:371-8
   PubMedGoogle Scholar
• Chou SH, Smith EE, Badjatia N, A randomized, double-blind, placebo-controlled pilot study of simvastatin in aneurysmal subarachnoid hemorrhage. Stroke 2008;39:2891-3
   PubMed Web of Science ®Google Scholar
• Lynch JR, Wang H, McGirt MJ, Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial. Stroke 2005;36:2024-6
   PubMed Web of Science ®Google Scholar
• Kern M, Lam MM, Knuckey NW, Statins may not protect against vasospasm in subarachnoid haemorrhage. J Clin Neurosci 2009;16:527-30
   PubMed Web of Science ®Google Scholar
• Vergouwen MD, Meijers JC, Geskus RB, Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial. J Cereb Blood Flow Metab 2009;29:1444-53
   PubMed Web of Science ®Google Scholar
• Vergouwen MD, de Haan RJ, Vermeulen M, Effect of statin treatment on vasospasm, delayed cerebral ischemia, and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update. Stroke 2010;41:e47-52
   PubMed Web of Science ®Google Scholar
• Tseng MY. Summary of evidence on immediate statins therapy following aneurysmal subarachnoid hemorrhage. Neurocrit Care 2011;15:298-301
   PubMed Web of Science ®Google Scholar
• Sillberg VA, Wells GA, Perry JJ. Do statins improve outcomes and reduce the incidence of vasospasm after aneurysmal subarachnoid hemorrhage: a meta-analysis. Stroke 2008;39:2622-6
   PubMed Web of Science ®Google Scholar
• Grasso G, Tomasello F. Erythropoietin for subarachnoid hemorrhage: is there a reason for hope? World Neurosurg 2012;77:46-8
   PubMedGoogle Scholar
• Springborg JB, Ma X, Rochat P, A single subcutaneous bolus of erythropoietin normalizes cerebral blood flow autoregulation after subarachnoid haemorrhage in rats. Br J Pharmacol 2002;135:823-9
   PubMed Web of Science ®Google Scholar
• Tseng MY, Hutchinson PJ, Richards HK, Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a phase II randomized, double-blind, placebo-controlled trial. Clinical article. J Neurosurg 2009;111:171-80
   PubMed Web of Science ®Google Scholar
• Feiler S, Plesnila N, Thal SC, Contribution of matrix metalloproteinase-9 to cerebral edema and functional outcome following experimental subarachnoid hemorrhage. Cerebrovasc Dis 2011;32:289-95
   PubMed Web of Science ®Google Scholar
• Suzuki H, Hasegawa Y, Ayer R, Effects of recombinant osteopontin on blood-brain barrier disruption after subarachnoid hemorrhage in rats. Acta Neurochir Suppl 2011;111:231-6
   PubMedGoogle Scholar
• Duris K, Manaenko A. Suzuki H, et al. {alpha}7 nicotinic acetylcholine receptor agonist PNU-282987 attenuates early brain injury in a perforation model of subarachnoid hemorrhage in rats. Stroke 2011;42:3530-6
   PubMed Web of Science ®Google Scholar
• Sherchan P, Lekic T, Suzuki H, Minocycline improves functional outcomes, memory deficits, and histopathology after endovascular perforation-induced subarachnoid hemorrhage in rats. J Neurotrauma 2011;28:2503-12
   PubMed Web of Science ®Google Scholar
• Ayer R, Jadhav V, Sugawara T, The neuroprotective effects of cyclooxygenase-2 inhibition in a mouse model of aneurysmal subarachnoid hemorrhage. Acta Neurochir Suppl 2011;111:145-9
   PubMedGoogle Scholar
• Thal SC, Sporer S, Schmid-Elsaesser R, Inhibition of bradykinin B2 receptors before, not after onset of experimental subarachnoid hemorrhage prevents brain edema formation and improves functional outcome. Crit Care Med 2009;37:2228-34
   PubMed Web of Science ®Google Scholar
• Diringer MN. Management of aneurysmal subarachnoid hemorrhage. Crit Care Med 2009;37:432-40
   PubMed Web of Science ®Google Scholar
• Rose FC, Sarner M. Epilepsy after ruptured intracranial aneurysm. Br Med J 1965;1:18-21
   PubMed Web of Science ®Google Scholar
• Sakowitz OW, Raabe A, Vucak D, Contemporary management of aneurysmal subarachnoid hemorrhage in germany: results of a survey among 100 neurosurgical departments. Neurosurgery 2006;58:137-45
   PubMed Web of Science ®Google Scholar
• Lanzino G, D'Urso PI, Suarez J. Seizures and anticonvulsants after aneurysmal subarachnoid hemorrhage. Neurocrit Care 2011;15:247-56
   PubMed Web of Science ®Google Scholar
• Butzkueven H, Evans AH, Pitman A, Onset seizures independently predict poor outcome after subarachnoid hemorrhage. Neurology 2000;55:1315-20
   PubMed Web of Science ®Google Scholar
• Hart RG, Byer JA, Slaughter JR, Occurrence and implications of seizures in subarachnoid hemorrhage due to ruptured intracranial aneurysms. Neurosurgery 1981;8:417-21
   PubMed Web of Science ®Google Scholar
• Naidech AM, Kreiter KT, Janjua N, Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage. Stroke 2005;36:583-7
   PubMed Web of Science ®Google Scholar
• Pinto AN, Canhao P, Ferro JM. Seizures at the onset of subarachnoid haemorrhage. J Neurol 1996;243:161-4
   PubMed Web of Science ®Google Scholar
• Rosengart AJ, Huo JD, Tolentino J, Outcome in patients with subarachnoid hemorrhage treated with antiepileptic drugs. J Neurosurg 2007;107:253-60
   PubMed Web of Science ®Google Scholar
• Zubkov AY, Wijdicks EF. Antiepileptic drugs in aneurysmal subarachnoid hemorrhage. Rev Neurol Dis 2008;5:178-81
   PubMedGoogle Scholar
• Chumnanvej S, Dunn IF, Kim DH. Three-day phenytoin prophylaxis is adequate after subarachnoid hemorrhage. Neurosurgery 2007;60:99-102
   PubMed Web of Science ®Google Scholar
• Dorhout Mees SM, van den Bergh WM, Algra A, Antiplatelet therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2007;CD006184
   PubMed Web of Science ®Google Scholar
• McGirt MJ, Woodworth GF, Ali M, Persistent perioperative hyperglycemia as an independent predictor of poor outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg 2007;107:1080-5
   PubMed Web of Science ®Google Scholar
• Kruyt ND, Biessels GJ, DeVries JH, Hyperglycemia in aneurysmal subarachnoid hemorrhage: a potentially modifiable risk factor for poor outcome. J Cereb Blood Flow Metab 2010;30:1577-87
   PubMed Web of Science ®Google Scholar
• Van den Berghe G, Schoonheydt K, Becx P, Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 2005;64:1348-53
   PubMed Web of Science ®Google Scholar
• Bell DA, Strong AJ. Glucose/insulin infusions in the treatment of subarachnoid haemorrhage: a feasibility study. Br J Neurosurg 2005;19:21-4
   PubMed Web of Science ®Google Scholar
• Kanamaru K, Weir BK, Simpson I, Effect of 21-aminosteroid U-74006F on lipid peroxidation in subarachnoid clot. J Neurosurg 1991;74:454-9
   PubMed Web of Science ®Google Scholar
• Steinke DE, Weir BK, Findlay JM, A trial of the 21-aminosteroid U74006F in a primate model of chronic cerebral vasospasm. Neurosurgery 1989;24:179-86
   PubMed Web of Science ®Google Scholar
• Zuccarello M, Marsch JT, Schmitt G, Effect of the 21-aminosteroid U-74006F on cerebral vasospasm following subarachnoid hemorrhage. J Neurosurg 1989;71:98-104
   PubMed Web of Science ®Google Scholar
• Zhang S, Wang L, Liu M, Tirilazad for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2010;CD006778
   Google Scholar
• Jang YG, Ilodigwe D, Macdonald RL. Metaanalysis of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care 2009;10:141-7
   PubMed Web of Science ®Google Scholar
• Claassen J, Carhuapoma JR, Kreiter KT, Global cerebral edema after subarachnoid hemorrhage: frequency, predictors, and impact on outcome. Stroke 2002;33:1225-32
   PubMed Web of Science ®Google Scholar
• Thal SC, Sporer S, Klopotowski M, Brain edema formation and neurological impairment after subarachnoid hemorrhage in rats. J Neurosurg 2009;111:988-94
   PubMed Web of Science ®Google Scholar